Agyemang C, Kunst A, Bhopal R, Zaninotto P, Nazroo J, Nicolau M, Unwin N, van Valkengoed I, Redekop K, Stronks K. Dutch versus English advantage in the epidemic of central and generalised obesity is not shared by ethnic minority groups: comparative secondary analysis of cross-sectional data. International Journal of Obesity 2011; (35):1334-1346.
Agyemang C, Kunst AE, Bhopal R, Anujuo K, Zaninotto P, Nazroo J, Nicolaou M, Unwin N, van Valkengoed I, Redekop WK, Stronks K. Diabetes Prevalence in Populations of South Asian Indian and African Origins: A Comparison of England and The Netherlands. Epidemiology. 2011 Jul;22(4):563-567.
Agyemang C, Kunst AE, Bhopal RAJ, Zaninotto P, Unwin N, Nazroo J, Nicolaou M, Redekop WK, Stronks K. Hypertensie in Nederlandse en Engelse etnische minderheidsgroepen. Bloeddruk in engelse groepen beter onder controle dan in nederlandse. Nederlands Tijdschrift voor Geneeskunde 2011; 155:A3318.
Agyemang C, Kunst AE, Bhopal R, Zaninotto P, Unwin N, Nazroo J, Nicolaou M, Redekop WK, Stronks K. Hypertension in Dutch and English ethnic minorities. Blood pressure better controlled in English groups than in Dutch groups. Ned Tijdschr Geneeskd. 2011;155(18):A3318.
Albers-Heitner PC, Lagro-Janssen TA, Joore MM, Berghmans BL, Nieman FF, Venema PP, Severens JJ, Winkens RR. Effectiveness of involving a nurse specialist for patients with urinary incontinence in primary care: results of a pragmatic multicentre randomised controlled trial. Int J Clin Pract. 2011 Jun;65(6):705-712.
Alemao E, Rajagopalan S, Yang S, Curiel RE, Purvis J, Al MJ. Inverse probability weighting to control for censoring in a post hoc analysis of quality-adjusted survival data from a clinical trial of temsirolimus for renal cell carcinoma. Journal of Medical Economics Vol. 14, No. 2, 2011, 245-252.
van Baal P, Brouwer W. PAID 1.0 in Practice: A Brief Clarification Regarding its Possibilities and Limitations. Pharmacoeconimcs (2011). doi: 10.2165/11585600-000000000-00000.
van Baal PH, Engelfriet PM, Hoogenveen RT, Poos MJ, van den Dungen C, Boshuizen HC. Estimating and comparing incidence and prevalence of chronic diseases by combining GP registry data: the role of uncertainty. BMC Public Health. 2011 Mar 15;11:163.
van Baal PH, Engelfriet PM, Boshuizen HC, van de Kassteele J, Schellevis FG, Hoogenveen RT. Co-occurrence of diabetes, myocardial infarction, stroke, and cancer: quantifying age patterns in
the Dutch popuation using health survey data. Population Health Metrics 2011, 9:51.
van Baal PH, Wong A, Slobbe LC, Polder JJ, Brouwer WB, de Wit GA. Standardizing the inclusion of indirect medical costs in economic evaluations. Pharmacoeconomics. 2011 Mar 1; 29(3): 175-87.
Baeten SA, Baltussen RMPM, Uyl-de Groot CA, Bridges JFP, Niessen LW. Reducing Disparities in Breast Cancer Survival. The Effect of Large-Scale Screening of the Uninsured. The Breast Journal, Volume 17 Number 5, 2011 548-549.
van den Berg M, Smit F, Vos T, van Baal P.H.M. Cost-Effectiveness of Opportunistic Screening and Minimal Contact Psychotherapy to Prevent Depression in Primary Care Patients. PLoS ONE 1 August 2011, Volume 6, Issue 8, e22884.
van den Berg IM, Eleveld C, van der Hoeven M, Birnie E, Steegers AEP, Galjaard RJ, Laven JSE, van Doorninck JH. Defective deacetylation of histone 4 K12 in human oocytes is associated with advanced maternal age and chromosome misalignment. DOI:10.1093/humrep/der030
van den Berg TI, Robroek SJ, Plat JF, Koopmanschap MA, Burdorf A. The importance of job control for workers with decreased work ability to remain productive at work. DOI 10.1007/s00420-010-0588-1
Bijlenga D, Koopmans CM, Birnie E, Mol BW, van der Post JA, Bloemenkamp KW, Scheepers HC, Willekes C, Kwee A, Heres MH, Van Beek E, Van Meir CA, Van Huizen ME, Van Pampus MG, Bonsel GJ.Health-related quality of life after induction of labor versus expectant monitoring in gestational hypertension or preeclampsia at term. DOI: 10.3109/10641955.2010.486458
Boonen A, Severens JL. Evaluating treatment strategies in patients with early rheumatoid arthritis: merging modeling theory with clinical practice. J Rheumatol. 2011 Aug;38(8):1538-40.
Camejo RR, McGrath C, Herings R, Meerding W-J, Rutten F. Antihypertensive Drugs: A Perspective on Pharmaceutical Price Erosion and Its Impact on Cost-Effectiveness. Value in Health. Oktober 2011. doi:10.1016/j.jval.2011.08.1736.
Cramm JM, Strating MMH, Tsiachristas A, Nieboer AP. Development and validation of a short version of the Assessment of Chronic Illness Care (ACIC) in Dutch Disease Management Programs. Health Qual Life Outcomes. 2011; 9:49. doi: 10.1186/1477-7525-9-49.
Christiaans I, Birnie E, Bonsel GJ, Mannens MMAM, Michels M, Majoor-Krakauer D, Dooijers D, van Tinelen P, van den Berg PM, Volders PGA, Arens YH, van den Wijngaard A, Atsma DE, Helderman-van den Enden ATJM, Houweling AC, de Boer K, van der Smagt JJ, Hauer RNW, Marcelis CLM, Timmermans J, van Langen IM, Wilde AAM. Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategy. doi:10.1093/eurheartj/ehr092
Drummond M, Jönsson B, Rutten F, Stargardt T. Reimbursement of pharmaceuticals: reference pricing versus health technology assessment. Eur J Health Econ. 2011 Jun;12(3):263-71. Epub 2010 Aug 28.
Engelfriet PM, Hoogenveen RT, Boshuizen HC, van Baal PH. To die with or from heart failure: a difference that counts: Is heart failure underrepresented in national mortality statistics? Eur J Heart Fail. 2011 Apr;13(4):377-83.
van Es PP, Luisterburg PAJ, Dekker J, Koopmanschap MA, Bohnen AM, Verhaar JAN, Koes BW, Bierma-Zeinstra SMA. Cost-effectiveness of exercise therapy versus general practitioner care for osteoarthritis of the hip: design of a randomised clinical trial. BMC Musculoskeletal Disorders 2011.
Feenstra TL, van Baal PM, Jacobs-van der Bruggen MO, Hoogenveen RT, Kommer GJ, Baan CA. (2011)Targeted versus universal prevention. a resource allocation model to prioritize cardiovascular prevention. Cost Eff Resour Alloc. 2011 Oct 6;9(1):14.
Gaultney JG, Redekop WK, Sonneveld P, Uyl-de Groot, C. Critical review of economic evaluations in multiple myeloma: An overview of the economic evidence and quality of the methodology. European Journal of Cancer 47 (2011) 1458-1467.
Gaultney JG, Sanhueza E, Janssen JJ, Redekop WK, Uyl-de Groot CA. Application of cost-effectiveness analysis to demonstrate the potential value of companion diagnostics in chronic myeloid leukemia.Pharmacogenomics (2011);12(3);1-11.
van Gestel A, Webers CA, Beckers HJ, van Dongen MC, Severens JL, Hendrikse F, Schouten JS. The relationship between visual field loss in glaucoma and health-related quality-of-life. Eye (Lond). 2010 Dec;24(12):1759-69. Epub 2010 Nov 5.
Goossens LMA, Baker CL, Monz BU, Zou KH, Rutten-van Mölken MPMH. Adjusting for COPD severity in database research: developing and validating an algorithm. International Journal of COPD. 2011 Dec 5. DOI: http://dx.doi.org/10.2147/COPD.S26214.
Goossens LMA, Nivens MC, Sachs P, Monz BU, Rutten-van Molken PMH. Is the EQ-5D responsive to recovery from a moderate COPD exacerbation? Respiratory Medicine (2011) 105, 1195-1202.
Harford JB, Otero IV, Anderson BO, Cazap E, Gradishar WJ, Gralow JR, Kane GM, Niëns LM, Porter PL, Reeler AV, Rieger PT, Shockney LD, Shulman LN, Soldak T, Thomas DB, Thompson B, Winchester DP, Zelle SG, Badwe RA. Problem solving for breast health care delivery in low and middle resource countries (LMCs): consensus statement from the Breast Health Global Initiative. Breast. 2011 Apr;20 Suppl 2:S20-9. Epub 2011 Mar 4.
Heijink R, van Baal P, Oppe M, Koolman X, Westert G. Decomposing cross-country differences in quality adjusted life expectancy: the impact of value sets. Popul Health Metr. 2011 Jun 23;9(1):17.
Hendriks M, Brewster L, Wit F, Bolarinwa OA, Odusola AO, Redekop W, Bindraban N, Vollaard A, Alli S, Adenusi P, Agbede K, Akande T, Lange J, Schultsz C. Cardiovascular disease prevention in rural Nigeria in the context of a community based health insurance scheme: Qualtiy Improvement Cardiovascular care Kwara-I (Quick-I). BMC Public Health 2011, 11:186.
Hoogendoorn M, Hoogenveen RT, Rutten-van Molken MP, Vestbo J, Feenstra TL. Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach. European Respiratory Journal 2011; 37: 508-515. DOI: 10.1183/09031936.00043710.
Hoogendoorn M, Rutten-van Mölken MPMH, Hoogenveen RT, Al MJ, Feenstra TL. Developing and Applying a Stochastic Dynamic Population Model for Chronic Obstructive Pulmonary Disease. Value in Health. Volume 14, Issue 8, December 2011, Pages 1039-1047. doi:10.1016/j.jval.2011.06.008.
Hoogveldt B, Rive B, Severens J, Maman K, Guilhaume C. Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer’s disease in the Netherlands. Neuropsychiatric Disease and Treatment (2011).doi: 10.2147/NDT.S19239.
Hoefman RJ, van Exel NJ, Foets M, Brouwer WB. 2011. Sustained informal care: The feasibility, construct validity and test-retest reliability of the CarerQol-instrument to measure the impact of informal care in long-term care. Aging & Mental Health. Nov;15(8):1018-27.
Hoefman RJ, Exel, van NJA, Jong, de SL, Redekop WK, Brouwer WBF. A new test of the construct validity of the CarerQol instrument: measuring the impact of informal care giving. Quality of Life Reseach 2011 20:875-887
Hoomans T, Ament AJ, Evers SM, Severens JL. Implementing guidelines into clinical practice: what is the value? J Eval Clin Pract. 2011 Aug;17(4):606-614. Epub 2010 Oct 4.
Kanters TA, Hagemans MLC, van der Beek NAME, Rutten FFH, van der Ploeg AT, Hakkaart L. Burden of illness of Pompe disease in patients only receiving supportive care. Journal of Inherited Metabolic Disease. doi: 10.1007/s10545-011-9320-x.
van de Kassteele J, Hoogenveen RT, Engelfriet PM, van Baal PH, Boshuizen HC. Estimating net transition probabilities from cross-sectional data with application to risk factors in chronic disease modeling. Stat Med. 2011 Dec 5. doi: 10.1002/sim.4423. [Epub ahead of print]
Koedoot C, Bouwmans C, Franken MC, Stolk E. Quality of life in adults who stutter. Journal of Communication Disorders. doi:10.1016/j.jcomdis.2011.02.002.
Koedoot C, Versteegh M, Yaruss JS. Psychometric evaluation of the Dutch translation of the Overall Assessment of the Speaker’s Experience of Stuttering for adults (OASES-A-D). Journal of Fluency Disorders.doi:10.1016/j.jfludis.2011.03.002.
Krol M, Papenburg J, Koopmanschap M, Brouwer M. Do productivity costs matter? The impact of including productivity costs on the incremental costs of interventions targeted at depressive disorders. Pharmacoeconomics (2011). doi: 10.2165/11539970-000000000-00000.
Lemmens KM, Rutten-Van Mölken MP, Cramm JM, Huijsman R, Bal RA, Nieboer AP. Evaluation of a large scale implementation of disease management programmes in various Dutch regions: a study protocol. BMC Health Serv Res. 2011 Jan 10;11(1):6.
Majer IM, Nusselder WJ, Mackenbach JP, Klijs B, van Baal PH Mortality Risk Associated With Disability: A Population-Based Record Linkage Study. American Journal of Public Health. 2011;101(12): e9-15. doi 10.2105/AJPH.2011.300361. Epub 2011 Oct 20.
De Meijer C, Koopmanschap M, D’ Uva TB, van Doorslaer E. Determinants of long-term care spending: Age, time to death or disability? J Health Econ. 2011 Mar;30(2):425-38. Epub 2011 Jan 13.
Oppe M, Al M, Rutten-van Molken, M. Comparing Methods of Data Synthesis. Re-Estimating Parameters of an Existing Probabilistic Cost-Effectiveness Model (2011). Pharmacoeconomics 2011; 29 (3): 239-250.
Petrillo J, van Nooten F, Jones P, Rutten-van Molken M. Utility Estimation in Chronic Obstructive Pulmonary Disease. Pharmacoeconomics 2011; 29 (11): 917-932.
Poeran J, Denktas S, Birnie E, Bonsel GJ, Steegers EAP. Urban perinatal health inequalities. The Journal of Maternal-Fetal and Neonatal Medicine, April 2011; 24(4): 643–646.
Ramos GFP, Kuiper S, Dompeling E, van Asselt ADI, de Grauw WJC, Knottnerus JA, van Schayck OCP, Schermer TRJ, Severens JL. Structuring and validating a cost-effectivenessmodel of primary asthma prevention amongst children. BMC Medical Research Methodology 2011, 11:150.
van Steenbergen-Weijenburg KM, van Puffelen AL, Horn EK, Nuyen J, van Dam PS, van Benthem TB, Beekman AT, Rutten FF, Hakkaart-van Roijen L, van der Feltz-Cornelis CM. More co-morbid depression in patients with Type 2 diabetes with multiple complications. An observational study at a specialized outpatient clinic. Diabet Med. 2011 Jan;28(1):86-9.
Tan SS, Van Putten E, Nijdam WM, Hanssens P, Beute GN, Nowak PJ, Dirven CM, Hakkaart-van Roijen L. A microcosting study of microsurgery, LINAC radiosurgery, and gamma knife radiosurgery in meningioma patients. J Neurooncol. 2011 Jan;101 (2): 237-45. Epub 2010 Jun 6.
Tielen M, van Exel NJ, van Buren MC, Maasdam L, Weimar W. Attitudes towards medication non-adherence in elderly kidney transplant patients: a Q methodology study. Nephrol Dial Transplant. 2011 May;26(5):1723-8. Epub 2010 Oct 12.
Timmermans S, Bonsel GJ, Steegers-Theunissen RPM, Mackenbach JP, Steyerberg EW, Raat H, Verbrugh HA, Tiemeier HW, Hofman A, Birnie E, Looman CWN, Jaddoe, VWV, Steegers EAP. Individual accumulation of heterogeneous risks explains perinatal inequalities within deprived neighbourhoods. European Journal of Epidemiology 2011; 26(2): 165-180. DOI 10.1007/s10654-010-9542-5.
Tsiachristas A, Hipple-Walters B, Lemmens KMM, Nieboer AP, Rutten-van Mölken MPMH. Towards integrated care for chronic conditions: Dutch policy developments to overcome the (financial) barriers. Health Policy. 2011 Jul;101(2):122-32. Epub 2010 Nov 9.
Vemer P, Rutten-van Mölken MPMH. Largely ignored: the impact of the threshold value for a QALY on the importance of a transferability factor. DOI 10.1007/s10198-010-0253-3
Verelst SG, Termorshuizen F, Uyl-de Groot CA, Schaafsma MR, Ammerlaan AH, Wittebol S, Sinnige HA, Zweegman S, van Marwijk Kooy M, van der Griend R, Lokhorst HM, Sonneveld P, Wijermans PW; Dutch-Belgium Hemato-Oncology Cooperative Group (HOVON). Effect of thalidomide with melphalan and prednisone on health-related quality of life (HRQoL) in elderly patients with newly diagnosed multiple myeloma: a prospective analysis in a randomized trial. Ann Hematol. 2011 Apr 7. [Epub ahead of print].
Versteegh MM, Leunis A, Luime JJ, Boggild M, Uyl-de Groot CA, Stolk EA. Mapping QLQ-C30, HAQ, and MSIS-29 on EQ-5D. Med Decis Making published online 22 November 2011. DOI: 10.1177/0272989X11427761.
Vogelmeier C, Hederer B, Glaab T, Schmidt H, Rutten-van Molken MPMH, Beeh KM, Rabe KF, Fabbri LM. Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPD. The New England Journal of Medicine 364;12 March 24, 2011.